Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 165
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03016468 | Safety of Transition From Selexipag to Remodulin® Then Oral Treprostinil in Symptomatic Adult PAH | ||
| NCT06425796 | Adiposity and Iron Requirements in Pregnancy | ||
| NCT00458042 | Transitioning To IV Remodulin From Ventavis in Patients With PAH: Safety, Efficacy and Treatment Satisfaction | ||
| NCT01268553 | Transition From Injectable Prostacyclin Medication to Inhaled Prostacyclin Medication | ||
| NCT06374459 | Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis | ||
| NCT00911248 | PTC299 for Treatment of Neurofibromatosis Type 2 | ||
| NCT00775463 | Digital Ischemic Lesions in Scleroderma Treated With Oral Treprostinil Diethanolamine | ||
| NCT01477333 | Addition of UT-15C SR to Pulmonary Arterial Hypertension Patients Currently Receiving Tyvaso® | ||
| NCT00147199 | Clinical Investigation Into Inhaled Treprostinil Sodium in Patients With Severe Pulmonary Arterial Hypertension (PAH) | ||
| NCT07037836 | Inhaled Treprostinil (Tyvaso Nebulizer) For COPD Patients With Hypoxemia | ||
| NCT03047369 | The Myelin Disorders Biorepository Project | ||
| NCT03180957 | Repurposing Anti-TNF for Treating Dupuytren's Disease | ||
| NCT03683186 | A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension | ||
| NCT01494896 | Impact of Inhaled Treprostinil Sodium on Ventilation Perfusion Matching | ||
| NCT00848107 | Open-Label Study of Oral Treprostinil in Digital Ulcers | ||
| NCT03037580 | Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction | ||
| NCT06964009 | DT2216 + Paclitaxel in Platinum-Resistant Ovarian Cancer | ||
| NCT02279160 | Safety and Efficacy of APD811 in Pulmonary Arterial Hypertension | ||
| NCT07612488 | A Study of CS231295 in Patients With Advanced Solid Tumors | ||
| NCT06814717 | A Safety, Tolerability and Pharmacokinetic Study of cP12 in Adults With Up To 10% Total Body Surface Area Burns | ||
| NCT02583789 | Assess Efficacy of of Oral Treprostinil in Patients With Symptomatic Primary or Secondary Raynaud's Phenomenon | ||
| NCT02603068 | Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis | ||
| NCT01884038 | Safety and Efficacy of Perioperative Remodulin® in Orthotopic Liver Transplant Recipients | ||
| NCT04411680 | Study of Sargramostim in Patients With COVID-19 | ||
| NCT00963001 | Effect of Food on the Pharmacokinetics of Oral Treprostinil | ||
| NCT05735249 | A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Oral ARN-75039 in Healthy Adult Subjects | ||
| NCT01027949 | An Open-Label Extension Trial of UT-15C Sustained-release (SR) in Subjects With Pulmonary Arterial Hypertension | ||
| NCT04050449 | Assess Therapeutic Efficacy and Emergence of HIV Drug Resistance Following Initiation of TLD | ||
| NCT00067041 | Effects of Remodulin in Patients With Critical Limb Ischemia Following a Vein Bypass Graft | ||
| NCT01042158 | A Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertension Associated With Systemic Sclerosis | ||
| NCT06878560 | Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With ESRD | ||
| NCT02693171 | Post-Marketing Assessment of Immunogenicity and Safety of Unituxin® in High-Risk Neuroblastoma Patients | ||
| NCT04850105 | A Non-interventional Cohort Safety Study of Patients With hATTR-PN | ||
| NCT03367312 | Assessing Response to Inhaled Prostacyclin With Hyperpolarized Xe MRI | ||
| NCT01447407 | Effect of Adjuvant & Route of Administration on Safety & Immunogenicity of NDV-3 Vaccine | ||
| NCT00741819 | Safety Evaluation of Inhaled Treprostinil Administration Following Transition From Inhaled Ventavis in Pulmonary Arterial Hypertension (PAH) Subjects | ||
| NCT05776225 | Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection | ||
| NCT05203510 | A Study of a Mean Pulmonary Artery Pressure-Targeted Approach With Early and Rapid Treprostinil Therapy to Reverse Right Ventricular Remodeling in Participants With Pulmonary Arterial Hypertension | ||
| NCT01795950 | Safety Study of PLX-PAD Cells to Treat Pulmonary Arterial Hypertension (PAH) | ||
| NCT02276872 | Safety, Tolerability, and Pharmacokinetics of Oral Treprostinil in Pediatric PAH Patients Aged 7 to 17 Years | ||
| NCT03055221 | TRUST-2: Safety and Efficacy of Intravenous Remodulin® in Patients in India With Pulmonary Arterial Hypertension (PAH) | ||
| NCT02882126 | An Open Label Extension Study to Evaluate the Safety of Continued Therapy of Subcutanous Remodulin® in Pulmonary Arterial Hypertension | ||
| NCT01560637 | An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension | ||
| NCT00692354 | Safety Study to Evaluate CHR-2797 in Patients With Advanced Tumours | ||
| NCT01273922 | Safety and Immunogenicity Study of a Recombinant Protein Vaccine (NDV-3) Against S.Aureus and Candida | ||
| NCT02847260 | Safety and Tolerability of Rapid Dose Titration of Subcutaneous Remodulin® Therapy in PAH Subjects (RAPID) | ||
| NCT01934582 | A Pharmacokinetic Substudy of the TDE-PH-304 Protocol | ||
| NCT01393795 | Qutenza®-Remodulin® in Pulmonary Arterial Hypertension Patients | ||
| NCT00848939 | Pharmacokinetics of Oral Treprostinil in Patients With Systemic Sclerosis | ||
| NCT03794583 | Inhaled Treprostinil in Participants With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD) |
